Delivery Order SPE2DB20D2014-SPE2DB25FB12V

Award Date 2/20/25
Potential Completion Date 2/21/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) and has a ceiling value of $23,546.39. The contract is for the delivery of Ondansetron ODT 4 mg tablets in quantities of 30 per bottle, with a completion date of January 30, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,978.24 firm fixed price delivery order contract is for the supply of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of July 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the supply of Ondansetron ODT 4 MG tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $6,281.99 firm fixed-price delivery order has a completion date of March 6, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Ondansetron ODT 4 mg tablets. The $2,537.64 firm-fixed-price delivery order contract has a completion date of January 10, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ondansetron ODT 8 mg tablets. The award, made by the Defense Logistics Agency (DLA), is a Delivery Order under an Indefinite Delivery Contract (IDC) with a ceiling value of $4,354.88 and a period of performance through November 1, 2024. The contract is for Firm Fixed Price with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 IDC with...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The Firm Fixed Price delivery order has a ceiling value of $13,140.34 and runs through November 2024. There is no set-aside designation for this award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,707.55 firm fixed price delivery order is for the supply of 4,566,197,426 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Ondansetron ODT 4 mg tablets. The contract has a total ceiling value of $5,615.65 and a performance period through April 2024. It is a firm fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides the Defense Logistics Agency (DLA) with a range of pharmaceutical products and medical supplies for military treatment programs and facilities worldwide. The $10,302.24 Firm Fixed Price Delivery Order contract covers the supply of Ondansetron HCL 4 mg tablets, with a completion date of July 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,241.75 Firm Fixed Price Delivery Order is for the supply of Ondansetron ODT 4 mg Tablets in quantities of 30s. The contract has an ultimate completion date of September 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB12V
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Ondansetron ODT 4 mg tablets. The contract has a ceiling value of $3,958.08 and a completion date of February 21, 2025. This is a Firm Fixed Price Delivery Order contract, and it is not designated with a set-aside requirement.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/22/25, 8:31 PM